Integrative East-West medicine can optimize the quality of life for patients with cancer, according to Dr. Malcolm Taw, assistant clinical professor of medicine at the UCLA Center for East-West Medicine.

The techniques can treat symptoms or side effects commonly associated with chemotherapy, radiation therapy and surgery, he said. These side effects can include pain, nausea, fatigue, insomnia, peripheral neuropathy, vasomotor hot flashes, lymphedema, chemo brain and anxiety, he said.

On Monday, Taw will present Cancer Care and Wellness through Integrative East-West Medicine at the Cancer Support Community, 530 Hampshire Road, Westlake.

Integrative East-West medicine is a health care paradigm that brings together the best of both conventional western biomedicine with traditional Chinese medicine to optimize patient care and outcomes, Taw said.

Perhaps the biggest myth about integrative East-West medicine is that there is no evidence in the medical literature for the treatments that we offer for our patients.

This may stem from the lack of understanding and experience about these therapies, such as acupuncture, he said.

However, there is actually an extensive amount of research about acupuncture describing its physiological mechanisms within the human body and demonstrating its benefit for various symptoms and conditions, Taw said.

Board certified by the American Board of Internal Medicine and the National Certification Commission for Acupuncture and Oriental Medicine in Oriental Medicine, Acupuncture and Chinese Herbology, Taw has treated patients with cancer, usually in collaboration with their oncologists and other health care providers, during different stages of the cancer process.

He has completed fellowships in integrative medicine at the UCLA Center for East-West Medicine and through the Bravewell Collaborative/University of Arizona Center for Integrative Medicine. Taw also has a Master of Science in Oriental Medicine and postdoctoral training through the National Institutes of Health-supported K30 Program in Translational Investigation at UCLA.

Dr. Taw is unique in his experience of both east and west medicine, said Tricia Lethcoe, a marriage and family therapist intern and program associate with the Cancer Support Community. With this background, Dr. Taw is able to provide information to participants about traditional Chinese medicine and how it can work with the treatments that someone may currently be undergoing.

Continued here:

Doctor to speak about integrative East-West medicine

Dr. Ron Noy, a Board Certified New York, NYphysician specializing in Sports Medicine, has been selected by Castle Connolly Medical Ltd. for inclusion in its authoritative guide to the top primary care and specialty care doctors in the tri-state metropolitan New York area.

NEW YORK, March 14, 2013 /PRNewswire/ -- Castle Connolly Medical Ltd., America's trusted source for identifying Top Doctors, has published the 16th edition of Top Doctors: New York Metro Area and has selected Ron Noy, MD for this exclusive honor.

(Photo: http://photos.prnewswire.com/prnh/20130314/DC77252)

The 16th edition of Top Doctors: New York Metro Area includes over 5,500 top primary care and specialty care physicians in a twenty-county area spanning three states: New York, New Jersey and Connecticut. Selected physicians, including Dr. Noy, represent the top 10% of doctors in the area in 65 medical specialties and subspecialties for the care and treatment of more than 1,800 diseases and medical conditions.

Castle Connolly Top Doctors are selected each year by Castle Connolly Medical Ltd. after being nominated by their peers in an online nomination process. Nominations are open to all board certified MDs and DOs and each year tens of thousands of physicians cast many tens of thousands of nominations. Nominated physicians are selected by the Castle Connolly physician-led research team based on criteria including medical education, training, hospital appointments, disciplinary histories and much more.

About Ron Noy: a short profile by and about the honoree:

Dr. Ron Noy, founder of Prestige Orthopaedics & Sports Medicine in midtown Manhattan, specializes in 4 arthroscopic knee and shoulder surgeries: ACL, meniscus, labrum, and rotator cuff. His reputation is getting his patients back to sports and work quicker with little or no post-operative pain. Dr. Noy sees every patient himself, giving a comprehensive examination. All patients have 24 hour access directly to Dr. Noy by cell and email. While Dr. Noy takes care of many professional athletes, musicians, actors and CEO's from all over the world, everyone is treated as a VIP.

For more information on this Castle Connolly New York Metro Area Top Doctor, please visitRon Noy's profile on http://www.castleconnolly.com.

Castle Connolly Medical Ltd.'s President and CEO Dr. John Connolly has this to say about Dr. Noy's recognition: "Roughly ten percent of area physicians were selected for our 16th edition of Top Doctors: New York Metro Area. Being nominated by Board Certified peers and then selected by our experts is an accomplishment worthy of recognition. The New York Metro area is home to a great number of very high quality medical professionals, yet some stand out. My congratulations to Dr. Noy."

To find out more or to contact Dr. Ron Noy ofNew York,NY, please call 646-862-0180, or visit http://www.PrestigeSportsMedicine.com.

See original here:

Dr. Ron Noy, Sports Medicine , is named a Top Doctor: New York Metro Area

WASHINGTON, DC--(Marketwire - Mar 14, 2013) - The American Association of Colleges of Osteopathic Medicine (AACOM) announces its support of the Training Tomorrow's Doctors Today Act, legislation introduced by U.S. Representatives Aaron Schock (R-IL) and Allyson Y. Schwartz (D-PA) to address the nation's physician workforce shortage and expand medical residency training positions in programs across the country.

"In the U.S. we are facing a significant physician shortage that will only increase in severity unless action is taken soon. Every eight seconds another Baby Boomer turns 65 so it's incumbent upon us to ensure we have a prepared physician workforce in place to meet the growing health care demands on our country," said Representative Schock. "The primary way our country can address the physician shortage is by ensuring we increase the number of Graduate Medical Education slots. By doing so, we are increasing the number of medical school graduates who will receive hands on training in a patient setting to gain the experience needed to become a practicing physician."

The Training Tomorrow's Doctors Today Act would increase the number of Medicare-funded graduate medical education (GME) positions by 3,000 each year, totaling 15,000 additional positions over the next five years. The legislation would give priority to hospitals in states with new medical schools and emphasize training in community-based settings. It would also require hospitals to train at least 30 percent of their residents in primary care and general surgery and require greater accountability and transparency by meeting specific performance measures.

The Balanced Budget Act of 1997, which currently is still in effect, capped the number of Medicare-funded residency positions. As osteopathic medical schools continue to graduate rising numbers of students, it is imperative to ensure that the number of medical residency positions increases simultaneously to continue training the nation's future physicians.

"The physician workforce shortage facing our nation, particularly in primary care, is a national crisis that requires comprehensive and cost-effective solutions," said AACOM President and CEO Stephen C. Shannon, D.O., M.P.H. "AACOM is pleased to offer its strong support of this critical legislation, which works to increase the training of the future physician workforce across the country while expanding access to patient care. AACOM commends Representatives Schock and Schwartz for their unwavering leadership on this issue."

About AACOMAACOM represents the nation's 29 colleges of osteopathic medicine at 37 locations in 28 states. Today, more than 21,000 students are enrolled in osteopathic medical schools. One in five U.S. medical students is training to become an osteopathic physician.

AACOM was founded in 1898 to support and assist the nation's osteopathic medical schools, and to serve as a unifying voice for osteopathic medical education. AACOM's mission is to promote excellence in osteopathic medical education, in research and in service, and to foster innovation and quality among osteopathic medical colleges to improve the health of the American public.

View original post here:

The American Association of Colleges of Osteopathic Medicine Supports Bipartisan Legislation to Expand Medical ...

BASKING RIDGE, N.J., March 13, 2013 /PRNewswire/ --Reproductive Medicine Associates of New Jersey, today announced the introduction of its new ReadyGO Donor Cycle Guarantee program designed to give couples faster access to donor eggs and multiple chances at IVF pregnancy success. Offered in partnership with NW Cryobank, a leader in frozen egg banking services based in Spokane, Washington, the ReadyGO program covers up to three withdrawals from NW Cryobank and the transfer of all embryos created from those eggs until a live birth is achieved. Should no live birth be achieved after all embryos created are transferred, a patient will receive a refund totaling about 80% of their initial outlay.

(Logo: http://photos.prnewswire.com/prnh/20120402/NY80340LOGO)

"ReadyGO was designed for donor recipients looking to cycle faster than a traditional fresh-donor approach, for which average wait lists can run nine months or more," said Thomas J. Kim, MD, FACOG, Director, Third Party Reproduction. "With the ReadyGO package, a patient can begin trying as early as her next cycle."

Added Dr. Kim, "ReadyGO offers a safe and effective path to pregnancy which can be put into place quickly and offers financial protection. A patient can undergo multiple cycles until a live birth is achieved, or until all embryos are transferred, for a single price."

"We are excited to partner with RMANJ to give patients participating in their donor egg program a faster solution to expand their family," said Tammy Zimmer, MT (ASCP), Managing Director, NW Cryobank. "Eggs from our donors listed on the NW Cryobank website are available immediately for donor recipients. All egg donors at NW Cryobank are medically, genetically and psychologically screened to ensure the best possible outcomes as part of the ReadyGO Donor Cycle Guarantee."

About ReadyGO Through the new program, patients are able to pay a package price which covers up to three withdrawals from NW Cryobank and the transfer of all embryos created from those eggs until a live birth is achieved. With RMANJ single cycle delivery rates in the 60% range (www.sart.org), many ReadyGO patients will achieve pregnancy in one cycle. Their cost at that point will have run about 35% more than a traditional "pay as you go" donor cycle, but they will have shortened their time to cycle by as many as nine months or more. If pregnancy is not achieved during the first cycle attempted, a patient can move quickly to the next cycle; after two attempts the cumulative delivery rates approach 80% and there is a cost savings over the "pay as you go" method of about 30%. If a third cycle is needed, patients have a greater than 85% chance of delivery at approximately half the cost of three "pay as you go" cycles. Should live birth not be achieved after all embryos created are transferred, a patient will receive a refund totaling about 80% of their initial outlay.

ReadyGO cannot be combined with insurance. Additional costs for medications and other service fees such as anesthesia may still apply. For more information, visit http://www.rmanj.com/readygo.

About Reproductive Medicine Associates of New Jersey Reproductive Medicine Associates of New Jersey have pioneered and successfully implemented a cutting-edge technology, known as Comprehensive Chromosome Screening (CCS) to more accurately detect healthy embryos that will lead to successful pregnancies and ultimately healthy babies. Other centers have attempted similar testing methods, but RMANJ is the only fertility center in the world to have developed a system of unprecedented accuracy, fully validated through years of rigorous clinical research. RMANJ's Comprehensive Chromosome Screening offers advanced embryo selection with extreme accuracy by detecting and avoiding use of embryos with chromosomal abnormalities prior to transfer and pregnancy.

The fertility experts at RMANJ have among the highest IVF success rates in the country. Since 1999, they have helped bring nearly 30,000 babies to loving families. In addition to serving as the Division of Reproductive Endocrinology at Robert Wood Johnson University Medical School in New Brunswick, NJ, the practice has seven locations in New Jersey. For more information please call RMANJ at 973-656-2089, or visit http://www.rmanj.com.

See the original post here:

New ReadyGO Donor Egg Cycle Program Launched By Reproductive Medicine Associates Of New Jersey

By Hironari Akiyama The Yomiuri Shimbun/Asia News Network Thursday, Mar 14, 2013

Companies making Chinese herbal medicine are stepping up efforts to ensure a stable supply of licorice, a major raw material for the medicine whose import price has increased by about 50 per cent over the past five years.

The price rise is due to tightened regulations on the harvest and export of licorice (kanzo in Japanese) imposed by leading licorice producer China for resource protection reasons.

The expectation of further reductions in licorice imports has led to the expansion of domestic licorice cultivation.

Licorice, a kind of legume, accounts for about 70 per cent of the raw material in as many as 500 kinds of Chinese herbal medicine. Licorice is considered a "rare plant" for which high-volume cultivation is difficult. More than 90 per cent of the licorice used for Chinese herbal medicine in Japan is imported from China.

There is increasing global demand for Chinese herbal medicine, especially as interest in oriental medicine grows in the United States and Europe.

In 2000, the Chinese government began controlling the harvest and export of the plant to prevent desertification in licorice vegetation areas due to overharvesting.

Since Japan imports licorice for Chinese herbal medicine production almost entirely from China, there has been concern that deteriorating relations between Tokyo and Beijing over the Senkaku Islands may adversely affect imports.

Chinese herbal medicine makers are stepping up efforts to boost stockpiles of Chinese licorice. Tsumura & Co., one of the largest Chinese herbal medicine makers, has secured about two years' supply of the plant.

A movement to grow the plant in Japan also has become active. Fukuoka-based midsize pharmaceutical company Shin Nihon Iyaku Corp. is aiming to grow its own licorice to use as raw material for Chinese herbal medicine on a large scale, following confirmation in February that the licorice it grew on an experimental basis in idle rice fields contains an important active ingredient.

More here:

Japan's herbal medicine industry worries as China restricts licorice supplies

Cindy Adams

Skin your knee? Got a boo-boo? Shove the salve. Poo on the pharmacist. Would Noah wait in his dermatologists cave office because of a zebra bite?

While picking the apple for Adam, suppose that snake bit Eve. Minus a friendly neighborhood druggist to unload a $75 unguent, shed have had to shop in the Garden of Eden. Scientific and medical restrictions would ban that today. Could be poison ivy. Shed need Benadryl. Shed need antihistamine. Veggies have pesticides. The kid Abel could contract zxppqycbvyiitis. And our health department would prescribe zip-lofan panxcroderm ziplozinc.

The old days did bush medicine. Rub with garlic. The Medecine Mans prescription read: Got a scrape? Get a clove. Youd smell, but you were healed. Also good for bites. Insect bites. Dog bites. Husband bites.

For piercing our ears, my grandma from the old country said: Saliva. Mouth to fingers to lobe. Perfect. Now? Antibiotics. Then a doc feels your purse and says, Nothing I can do.

Body ache. Tea from tall skinny fever grass weed. Boil in lukewarm water. And bathe your skin in it. Three days, youre fine. Also clean. Tell an internist: Every bone in my body hurts. Hell say: Be glad youre not a herring. Next.

Skin allergy. Stuff the salve. Boil a certain thick bark. Drink. No more allergy. The physicians regimen? Dont drink, eat, smoke, dissipate or do anything to interfere with paying my bill.

Fever. Boil cinnamon and clove. Drink often. Heats the body. Kills germs. Also kills off those MDs who once hit house calls Monday and golf clubs Wednesday.

Newborns. Midwives. Lay on the ground, palms pressed against a wall behind you. Twice a day for five days heal the bellybutton cord with warm coconut oil. The antiseptic? Rum.

Before Lipitor, what antediluvians did for high cholesterol, I dont know. Maybe tuna tartare with radicchio on a bed of chanterelles, shiitakes and portobellos. Mushrooms fight body fat. What they do for cholesterol, who knows?

Read more here:

Modern medicine ’s puzzling

STONY BROOK, N.Y., March 14, 2013 /PRNewswire/ --Charles A. Gargano, former U.S. Ambassador to Trinidad and Tobago and long-time friend of Stony Brook University, has agreed to establish the Ambassador Charles Gargano Chair in Advanced Cardiovascular Imaging at Stony Brook Medicine.

The $750,000 gift will be matched dollar for dollar by the Simons Foundation Challenge and Jim and Marilyn Simons, creating a $1,500,000 philanthropic impact. The funds will be used to attract an accomplished, research-oriented scientist and clinician who is dedicated to finding new methods of diagnosis and treatment. The holder will serve as an institutional leader in advanced cardiovascular imaging. Generous funding will enable staff to conduct research using imaging tools and working with the clinical population.

Though he is not a graduate of Stony Brook, Gargano has supported the University for many years. He helped establish a Chair and a Center for Italian Studies more than 25 years ago, and in 2005 he received an honorary doctorate from Stony Brook University to honor both his accomplishments and his generosity.

"I lived on Long Island for many years, and my professional career was on Long Island before I went into the world of politics," explained Gargano. "I have always thought of Stony Brook as an important institution. Recently, I have been impressed with the work of Stony Brook's Dr. Michael Poon, who inspired me to make my latest gift."

World-renowned cardiologist and imaging specialist Michael Poon, MD, came to Stony Brook in 2009, becoming Director of Advanced Cardiovascular Imaging at Stony Brook University Hospital and Professor of Radiology and Medicine (Cardiology) at Stony Brook University School of Medicine. Dr. Poon is one of the pioneers who helped develop CT imaging technologies to "photograph" the heart in motion, giving Emergency Room doctors the ability to more quickly and accurately diagnose the causes of chest pain. At Stony Brook, Dr. Poon literally changed the Emergency Room paradigm by recognizing the importance of advanced cardiac imaging.

"I saw that Dr. Poon's work related not only to better outcomes for people who present in Emergency Rooms with chest pain but also to cost savings and better efficiency for hospitals and congested Emergency Rooms," said Gargano, adding that Stony Brook University Hospital is making tremendous strides not only in imaging and cardiology, but also in cancer research and more. "The hospital is growing and is becoming increasingly more important to the people of Long Island."

"Ambassador Gargano has been a valued friend of the University for many years," said President Samuel L. Stanley Jr., MD. "This latest expression of his trust and confidence in our ability to advance the science of cardiovascular imaging is tremendously gratifying, and we will put his investment to good use right away."

Gargano has long been a champion of economic development and public service. Before becoming active in politics, he served as a construction engineer and a principal at the New York/New Jersey-based J.D. Posillico Engineering and Construction. He was appointed as Deputy Administrator of the Federal Urban Mass Transportation Administration in 1981, and then as Ambassador to Trinidad and Tobago, serving from 1988 to 1991. He was the Chairman and Commissioner of Empire State Development and also served as a Vice Chairman of Port Authority of New York and New Jersey from 1995 to 2007.

"Federal funding for research is dwindling," said Vice President for University Advancement Dexter Bailey. "We very much rely on the generosity of people like Ambassador Gargano--people who want to help society by supporting new ideas, new research, new technology, and the innovators who will provide solutions to great health challenges. The Gargano Chair in Advanced Cardiovascular Imaging is critically important, giving us the ability to continue to find ways to save lives, and we couldn't be more grateful."

Ultimately, Gargano hopes others will join him in reaching the $750,000 endowment goal. "Prospective donors who participate in this great opportunity will be helping advance cardiac imaging, which is such an important part of understanding and diagnosing individuals' problems," he explained. "Today it might be someone else, but tomorrow it might be ourselves. Private philanthropy is very important because it is the primary way for people to demonstrate their support for causes that matter to them. The Chair at Stony Brook is one of those important causes, and I hope Dr. Poon's work will inspire others."

Read the original post:

Stony Brook Medicine Receives $750,000 Pledge From Charles Gargano For Endowed Chair In Advanced Cardiovascular Imaging

DUBLIN, March 14, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/vghldf/personalized) has announced the addition of the "Personalized Medicine - A Global Market Overview" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

This report reviews, analyzes and projects the personalized medicine market for global and the regional markets including the United States, Europe and Rest of World. The market numbers illustrated in this report only represent the market exclusively for the product segments and technologies enunciated above. The market, in this report, does not include the associated hardware equipment or software technologies that are used to manage patient data. The study includes recent and current trends related to technology and the market along with the key industry developments.

The market for personalized medicine product types analyzed in this study includes Targeted Biologics, Proteomics & Genomics, Genetically Modified (GM) Products, Wellness & Disease Management, Other Molecular Diagnostics and Self/Other Diagnostics. The report also includes the market analysis for application technologies of personalized medicine - Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics, Pharmacogenetics and Other Technologies. The report analyses the global market in terms of USD Million.

This 350 page global market report includes 43 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of the market. The statistical tables represent the data for the global market by geographic region, product type and application technology.

The report covers the brief business profiles of 56 key global players and 77 major players across the United States - 45; Europe - 24; and Rest of World - 8.

The report also provides the listing of the companies engaged in research and development, manufacturing, processing, supplies and distribution of personalized. Also enlisting the academic institutions engages in personalized medicine, the global list covers the addresses, contact numbers and the website addresses of 395 companies.

For more information, including table of contents and list of companies mentioned, please visit http://www.researchandmarkets.com/research/vghldf/personalized

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Healthcare and Medical Devices

Excerpt from:

Research and Markets Announces the Release of 'Personalized Medicine - A Global Market Overview'

Escape Fire: "We need a whole new kind of medicine...
Some believe the U.S. health care system is due for a complete overhaul. "Escape Fire" examines the debate.

By: CNN

See the original post:

Escape Fire: "We need a whole new kind of medicine... - Video

Predictive Health: How We Can Reinvent Medicine to Extend Our Best Years (Extended)
Extended Version: Listen to Michael Johns and Kenneth Brigham discuss "Predictive Health: How We Can Reinvent Medicine to Extend Our Best Years." Predictive ...

By: EmoryUniversity

Read the original:

Predictive Health: How We Can Reinvent Medicine to Extend Our Best Years (Extended) - Video

Preview: Lethal Medicine
Scott Pelley investigates the source of tainted pain medication that caused fungal meningitis that has so far killed 48 Americans and sickened hundreds more....

By: CBSNewsOnline

Read the original:

Preview: Lethal Medicine - Video

Published: Monday, March 11, 2013 at 10:00 a.m. Last Modified: Monday, March 11, 2013 at 10:28 a.m.

Since its creation in 2010, the Sports Medicine Center at Thibodaux Regional Medical Center has helped provide free sports-medicine coverage to local high-school athletic teams.

The center is looking to raise awareness of its services by sponsoring a 5K race and half-mile run/walk at Oak Valley Plantation (located at 3645 La. 18) in Vacherie on Saturday.

The race, which is called "Reveille at Oak Alley," will start with registration at 7 a.m. Saturday, and the race will follow at 8 a.m. The entry fee is $25 for pre-registration and $30 on the day of the race.

Registration for 5K Run/Walk also includes admission to 22nd annual Oak Alley Spring Arts & Crafts Festival, which will be held on Saturday and Sunday from 9 a.m. to 5 p.m.

The course will be held entirely on the scenic grounds of Oak Alley Plantation, with a "spectacular finish" planned for participants who complete the race through the oaks of the historic site.

Awards for the 5K race will be handed out to winners of several divisions, including overall open winner, youth, masters, grandmasters and seniors.

The age groups range from 10-and-under to 80-and-over.

Awards will also be given out to the top 10 male and female youth age finishers in the half-mile race. Post-race refreshments will be provided for all runners.

The Sports Medicine Center at Thibodaux Regional Medical Center has provided several services to local high schools, which include free athletic-training care services at local high-school sporting events and donating 15 automatic external defibrillators (AEDs) to local high schools in the last two years.

Read this article:

Local race to benefit sports medicine center

Newswise San Francisco In the United States alone, an estimated 100,000 patients per year receive implantable cardioverter defibrillators (ICDs) devices that detect life-threatening heart rhythm irregularities and deliver a high-voltage shock to return the heart to a normal pace. Despite their lifesaving purpose, many patients and clinicians will ultimately be faced with difficult decisions about deactivation of these devices as patients age and develop other conditions that may prove terminal. Little is understood about physicians' views surrounding the ethical aspects of ICD deactivation in end-of-life situations, especially as it relates to other medical interventions and patient and family directives. Now, new research from the Perelman School of Medicine at the University of Pennsylvania has revealed that many electrophysiology practitioners believe ICD and pacemaker deactivation to be ethically distinct and that an ICD should not be deactivated without discussion with patients and families, even in the face of medical futility. The study results were reported today at the 2013 American College of Cardiology meeting in San Francisco (Abstract # 1277-28).

Decisions by medical providers not to resuscitate patients, despite patient and/or family wishes to the contrary, are extremely controversial. However, they have been argued to be ethically justified in cases of medical futility and may be gaining traction in an era of cost-consciousness, concern over ICU beds as a scarce resource, spiraling costs of care at the end of patients lives, and frustrations on the part of medical providers over the provision of futile care, said senior study author James N. Kirkpatrick, MD, assistant professor in the Cardiovascular Medicine Division and the Department of Medical Ethics and Health Policy at Penn. In general, medical providers are not expected to provide care they believe is futile. Most patients and providers see no ethical distinction between defibrillation by an ICD and external defibrillation in the performance of CPR. In this study, we sought to explore ethical beliefs of clinicians regarding deactivation of ICDs in end-of-life situations, including deactivation against patient and family/surrogate wishes, known as unilateral deactivation.

To better understand practitioners viewpoints, the research team polled 383 electrophysiology providers (including doctors, nurses, technicians) to gain insights into the ethical considerations involved in deactivation. Seventy-seven percent of respondents indicated that an ICD should not be unilaterally deactivated, whether against the wishes of a patient or against the wishes of the family/surrogate, even in the face of medical futility.

They also found that 43 percent of respondents believe that ICDs were not like any other medical intervention, including external defibrillation, dialysis, and coronary stents. In regards to other life-sustaining interventions, 73 percent of respondents indicated that deactivating an ICD was not ethically/morally different than not performing CPR; however, 83 percent of respondents indicated that deactivating a pacemaker was ethically/morally different than deactivating the shocking function of an ICD.

In our study, there was a mixed response regarding the ethical nature of ICDs and the justification for deactivating them in end-of-life situations, but most of the sample did not believe ICDs fit into any of our currently accepted categories for types of therapies we withdraw, such as mechanical ventilation, said Dr. Kirkpatrick. Based on these findings, we need to further explore ways to help clinicians address end-of-life management of ICDs.

Other authors from Penn include Margaret Grace Daeschler and Ralph J. Verdino, MD.

###

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The Perelman School of Medicine is currently ranked #2 in U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $479.3 million awarded in the 2011 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.

Read more:

Penn Medicine Study Examines Health Providers' Perspectives on ICD Deactivation In End-of-Life Situations

THE Philippine Society for Stem Cell Medicine has brought early March a technology in Iloilo City in a bid to promote stem cell medicine and therapy.

Mayor Jed Patrick Mabilog said the arrival of the stem cell medicine in Iloilo would attract tourists and for physicians to practice in the city.

Mabilog said aside from stem cell medicine, Iloilo City is ready to absorb other branches of science such as in-vitro fertilization and cryogenic as several hospitals have adequate facilities, specialist doctors and trained personnel to offer.

In Iloilo City alone, there are seven private tertiary hospitals and one government medical center, seven district health centers and more than 100 barangay health centers out of the 180 barangays, more than 20 private health service providers on top of private medical practitioners with their own clinics.

Society president Dr. Leo Olarte said a memorandum of agreement (MOA) will be forged between the association and St. Pauls Hospital here for the acceptance of the program and put up a stem cell center to serve the needs of the Ilonggos.

Olarte said stem cell medicine is a new wonder medicine and the cure of the future. Its successful effects had stemmed the tide of several devastating diseases today and it is considered a good cure for multiple sclerosis, Parkinsons disease, even tuberculosis, diabetes, HIV-Aids and all types of degenerative diseases.

Olarte said although the Department of Health (DOH) has approved the new technology, he warned that harvest of stem cells must be from the human body or the patient himself.

The DOH is expected to issue a guideline on stem cell medicine with the month of March.

The activated stem cells may come from the combined sources of blood, bone marrow and adipose tissue of the patient that maybe operated or injected in three to five hours operation, Olarte said.

The private hospitals operating in the city are Iloilo Doctors Hospital, St. Pauls Hospital, West Visayas University Hospital (Don Benito Hospital), Iloilo Mission Hospital, Medical City, St Therese Hospital and Amoesup International Hospital.

Read more here:

Stem cell medicine in Iloilo

The Austin Sports Medicine Doctors at Medicine in Motion Celebrate Marchs National Nutrition Month by Sharing Important Food-Related Healthcare Tips for Athletes of All Levels

Austin, Texas (PRWEB) March 11, 2013

Whether a person is new to physical fitness activities or a pro, sports nutrition can seem complicated. Many nutritionists create intense and detailed food regimens for their clients, but a solid nutrition program can be simple and still very beneficial. For those wanting the most from a diet and fitness routine but not interested in the details of sports nutrition, the following tips can help:

1. Daily balanced diet.

For consistent performance at the gym or with a sport, the body needs a regular supply of quality energy for the muscles. A few daily essentials for meeting the bodys needs include: a balanced breakfast; carbohydrates for fuel; and proteins and fats appropriate for a persons individual body-type and fitness goals.

2. Day of the workout.

For those tackling a workout first thing in the morning, be sure to have a light breakfast like fruit, toast, and/or an egg. For those who workout in the evenings, have a lunch that easily digestible but includes complex carbs. Pasta, fruits, vegetables or a salad with lean meat (chicken or fish) are good examples.

3. Immediately prior to workout.

About 30 minutes before an intense workout, eat a light to moderate snack and drink some water. The amount of food a person should ingest depends on the length and intensity of their upcoming workout. Longer, harder activities may require the individual to eat an energy bar or large banana.

4. During workout.

The rest is here:

National Nutrition Month Tips for Athletes from the Austin Sports Medicine Doctors at Medicine in Motion

MEDIA TOOLKIT

March 2013

Penn experts will present research findings that could come to define new standards of cardiovascular diagnostics and care at the 2013 American College of Cardiology Annual Scientific Sessions. Cardiovascular experts from around the world will gather in San Francisco, CA March 9 - 11 to present and discuss the latest advances in cardiovascular medicine, science and education.

Experts

To arrange interviews with Penn cardiovascular experts, please contact Jessica Mikulski at 215-349-8369, or email jessica.mikulski@uphs.upenn.edu or on Twitter (@PennMedNews). All research results are embargoed until the time they are presented during the conference.

News Releases

New Research Shows that While Niacin Added to Statin Therapy Increases HDL Cholesterol Levels It Does Not Improve HDL Functionality

Penn Medicine Researchers Show that Combination Therapy of CPAP and Weight Loss for Obstructive Sleep Apnea is Effective for Lowering Blood Pressure in Obese Patients

Penn Study Examines Health Providers' Perspectives on ICD Deactivation In End-of-Life Situations

Related Links

See the original post:

Penn Medicine at the 2013 American College of Cardiology Annual Scientific Sessions, March 9 11, San Francisco, CA

The following script is from "Lethal Medicine" which aired on March 10, 2013. Scott Pelley is the correspondent. Michael Radutzky, Oriana Zill de Granados and Michael Rey, producers.

Last fall, 17,000 vials of a steroid were shipped to clinics and hospitals in 23 states. The drug had to be sterile because patients would have it injected into their joints or their spines to relieve chronic pain. What happened next is the worst pharmaceutical disaster in decades.

The steroid was contaminated with fungus. Forty-eight people have been killed, 720 are being treated for persistent fungal infections. The tragedy has exposed a failure in drug safety. And, in a moment, you will hear the commissioner of the FDA acknowledge that she can no longer guarantee the safety of many high risk drugs.

The steroid was produced by New England Compounding Center and in the six months since the first deaths, no one at New England Compounding has revealed what happened. But tonight they will. As for the victims, this has been an unrelenting horror after just one injection of lethal medicine.

Julie Otto: I've been in the hospital seven times, total of 75 days. I've missed Thanksgiving and Christmas and my son's birthday.

Julie Otto is one of 13 injured patients who met us at St. Joseph Mercy Hospital outside Detroit.

Willard Mazure: I'm on 60 milligrams of morphine a day with no cure in sight. There is no cure in sight for me.

Willard Mazure's morphine is to kill the pain from the fungal infection. We asked the patients to sit down in the first two rows and many of them brought family to the auditorium. Michigan is a hotspot for the toxic steroid, one of 23 states that received the drug from Massachusetts. St. Joseph Mercy has treated 189 patients -- all of whom endure brutal anti-fungal drugs.

Willard Mazure: The medicine is just unbearable. You know, they talk about cancer treatments, and I'm sure they're unbearable too. But this is some unbearable stuff.

This is the fungus. It is a sample that has been grown from the spinal fluid of a patient. The fungus is a form of mold that attacks bone and nerves. The patients who had it injected in the spine have an infection called meningitis which can also reach the brain.

More here:

"60 Minutes": Lethal medicine linked to meningitis outbreak

NEW YORK, NY--(Marketwire - Mar 11, 2013) - TriMarkPublications.com cites in its newly published "Regenerative Medicine Markets" report that the regenerative medicine market will catapult to over $35 billion by 2019. For more information, visit: http://www.trimarkpublications.com/regenerative-medicine-markets/.

Regenerative medicine (RM) can be categorized into three main modalities: tissue engineering, biomaterials and biomolecules, e.g., scaffolds, growth factors and stem cell therapy. Tissue-engineered bone products in the orthopedic segment will see steady growth, from $7.5 billion in 2012 to $3.29 billion in 2019. The up-and-coming cardiology and vascular products segment will also see substantial growth, reaching a market value of $3.29 over the forecast period.

The "Regenerative Medicine Markets" report covers:

The "Regenerative Medicine Markets" report examines companies manufacturing regenerative medicine equipment and supplies in the world. Companies covered include: Amorcyte, Ars Arthro, Axiogenesis, AxoGen, Bellicum, BetaStem, Bioheart, Biomet, BioMimetic, BioTissue, Biovest, BrainStorm Cell, California Stem Cell, Cardio3, Cellartis, CellSeed, Cellular, Chromocell, Cognate, Cook, Cytomedix, Cytonet, Cytori, DanDrit, Fibrocell, Forticell, Gamida, Harvest, Histogenics, Humacyte, Integra, Intercytex, iPierian, Japan Tissue Engineering, Kensey Nash, Kiadis, Life Cell, Living Cell, MaxCyte, MediStem, Mesoblast, MolMed, NanoCor, Neuralstem, NeuroNova, NewLink Genetics, Olympus Terumo, OncoMed, Opexa, Organogenesis, Orthovita, Osiris, Osteotech, Pervasis, Pluristem, Proneuronnologies, RegeneRx, ReNeuron, Revivicor, SanBio, Saneron, Sangamo, Stem Cell Authority, StemCells, Stemline, Stratetech, Synthecon, Tengion, Thermogenesis, TiGenics, Tissue Genesis, ViaCyte, Vistagen and Zen-Bio.

Detailed charts with sales forecasts and marketshare data are included. For more information, visit: http://www.trimarkpublications.com/regenerative-medicine-markets/.

About TriMarkPublications.com

TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit http://www.trimarkpublications.com.

Important Notice

The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.

Link:

Regenerative Medicine Market to Catapult to Over $35 Billion by 2019

HUNTSVILLE, Ala.--(BUSINESS WIRE)--

ADTRAN, Inc. (ADTN), a leading provider of next-generation networking solutions, today announced that Medicine Park Telephone is deploying ADTRANs comprehensive broadband portfolio in its Broadband Stimulus funded, Fiber-to-the-Home (FTTH) high-speed broadband service. Currently served by a variety of Tier 1 and Tier 2 providers for telephony voice service, residents in these communities are vastly unserved up to 100% of the households in some of the regions by any type of high-speed broadband accessibility. Medicine Parks FTTH service opens up connectivity to thousands of households in these remote access communities some of which are isolated by a national wildlife refuge and others that reside in the former Kiowa-Comanche-Apache Reservation in southwestern Indian Territory.

Medicine Park Telephone is leveraging ADTRANs Total Access 5000 broadband access platform to deliver high-speed broadband, IP telephony and high-definition television services for the first time to residential customers plus high-value business Ethernet services to small business customers. The Total Access 5000 delivers these services over an all-Ethernet access platform with the GPON infrastructure providing up to 2.5Gbps of bandwidth. Medicine Park is also utilizing ADTRAN's modular Ethernet access gateway, the NetVanta 8044M, in combination with the Total Access 5000, for a complete end-to-end Ethernet access migration solution for 4G/LTE cell-site backhaul to further increase accessibility for its underserved customer base.

For so long, residents in our remote communities have been lucky just to have reliable phone service, let alone any sort of high-speed broadband capability. Now, for the first time, we are able to deliver any mix of telephone, internet and television services that our residential and business customers need to be connected with the rest of the country, said Eddie Hilliary, president, Medicine Park Telephone. With ADTRAN, we are able to do this with the latest optical network technology and can provide our customers with the most advanced, next-generation services and infrastructure.

Finding a way to get the maximum number of customers connected with high-bandwidth broadband access is a problem faced by many rural service providers today, said Mitch Fleming, vice president of sales for ADTRANs Carrier Networks Division. For Medicine Park Telephone, they found ADTRANs FTTH platform, based on the Total Access 5000, to be the most cost-effective solution that provides the ultra-high service density they need to reach their entire addressable market and ensure that no customer is left behind.

About Medicine Park Telephone Company

Medicine Park Telephone Company has been providing communications services in Medicine Park, Oklahoma and the surrounding areas since 1903. Services include telephone, Fiber-to-the-Home and DSL High-Speed Internet. For more information, visit: http://www.mptelco.com/.

About ADTRAN

ADTRAN, Inc. is a leading global provider of networking and communications equipment. ADTRANs products enable voice, data, video and Internet communications across a variety of network infrastructures. ADTRAN solutions are currently in use by service providers, private enterprises, government organizations, and millions of individual users worldwide. For more information, please visit http://www.adtran.com.

Read the original here:

Medicine Park Telephone and ADTRAN Deliver First FTTH Service for Remote Oklahoma Communities

Denver Alternative Medicine, Acupuncture, Natural Pediatrics, Applied Kinesiology, Homeopathy
Alternative Medicine in Denver, Colorado Springs, Castle Rock and Parker CO. Integrative Therapeutic Medicine using Natural Medicine, Biofeedback Screening, Applied Kinesiology, Acupuncture, German Biologic and Spagyric Medicines, Chinese Herbology, Homeopathy, Injection Therapy, Natural Pediatrics, Nutritional and Naturopathic Medicine.

By: webVDEOgroup

More:

Denver Alternative Medicine, Acupuncture, Natural Pediatrics, Applied Kinesiology, Homeopathy - Video